This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Blue Cross Blue Shield accused in US of suppressing demand for spinal fusions

( March 17, 2025, 22:31 GMT | Official Statement) -- MLex Summary: Spinal fusion company TranS1 filed a US complaint accusing the Blue Cross Blue Shield Association and its member plans of conspiring to keep out of the market by refusing to cover its services. TranS1 claims that as the dominant buyers of healthcare services and procedures, both in the national market and respective state markets in which they operate, BCBS and its affiliates have exercised monopsony power to unreasonably suppress demand for spinal fusions and TranS1's AxiaLIF specifically.See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections